Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Emblem Corp EMMBF

"Emblem Corp is a licensed producer of medical cannabis. It is intended to cultivate and cure cannabis for medicinal use. The group operates in the business segment of production and sale of medical cannabis."

OTCPK:EMMBF - Post Discussion

Emblem Corp > New Investor Presentation
View:
Post by deminimis on Jan 24, 2018 10:02am

New Investor Presentation

What’s this? Emblem is actually trying to engage with current and potential new investors??

https://emblemcorp.com/wp-content/uploads/2018/01/EM-IR-Deck-01-18.pdf

interesting tidbits:

None of the 3 founders are listed in the current managment team but John Stewart is still there. They are branding this as Emblem 2.0. Given everything that has happened in the last year I think this is a great thing.

They are hiring a Chief Marketing Officer.

The greenhouse is now projected to be completed by Jan 2019 and is referred to as “phase 1”. Building a smaller greenhouse is smart, building 1 Million sq ft in one go is very time consuming and will take a VERY long time to scale up to 100% capacity. Hopefully we see several more phases announced in the very near future. Maybe something like a new phase every 6 months similar to Aphria’s expansion plans.

The oral spray being developed with Dosecann is expected to be done and available for sales in Q3.

Current patient count is 2,800. Honestly, I’m not impressed with that. Patient aquisition needs to seriously ramp up.
Comment by Icebreak on Jan 24, 2018 11:49am
This post has been removed in accordance with Community Policy
Comment by gkmackdadzzz1 on Jan 24, 2018 1:24pm
This post has been removed in accordance with Community Policy
Comment by Buccwild on Jan 24, 2018 4:54pm
I would have liked the international expansion to be earlier than 2021. They already took too long to expand production here in Canada, let's not wait too long to get in the international market.  Question: they raised a few months back $50 million in order to fund their greenhouse expansion.  Most recently they raised another$ 50 million I believe. Do we know wha that raise was for ...more  
Comment by ewing1966 on Jan 24, 2018 6:05pm
$25M was raised in october and now $50M in january. For those wondering about current share price. Take a look at EMC's 2016 investor presentation next to the latest. They litteraly dropped the ball in 2017 as far as capacity is concerned. Capacity by june 2017 was projected to be at 11,600 kg (Phase 1-3) We won't see those numbers before year end 2018... This is why ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities
USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse